STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Sees Large Decrease in Short Interest

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 157,200 shares, a decline of 27.0% from the March 31st total of 215,200 shares. Based on an average daily volume of 26,000 shares, the days-to-cover ratio is presently 6.0 days. Approximately 0.9% of the shares of the company are short sold.

Institutional Investors Weigh In On STRATA Skin Sciences

A number of hedge funds have recently made changes to their positions in SSKN. Chicago Partners Investment Group LLC increased its position in STRATA Skin Sciences by 162.0% in the 4th quarter. Chicago Partners Investment Group LLC now owns 64,223 shares of the medical device company’s stock valued at $33,000 after acquiring an additional 39,706 shares during the period. Azzad Asset Management Inc. ADV boosted its holdings in shares of STRATA Skin Sciences by 289.5% in the first quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock valued at $25,000 after acquiring an additional 49,800 shares in the last quarter. Finally, 22NW LP boosted its holdings in shares of STRATA Skin Sciences by 56.1% in the third quarter. 22NW LP now owns 5,369,954 shares of the medical device company’s stock valued at $3,195,000 after acquiring an additional 1,930,693 shares in the last quarter. Institutional investors own 32.43% of the company’s stock.

STRATA Skin Sciences Stock Down 2.8 %

SSKN traded down $0.01 during trading on Friday, reaching $0.51. 7,598 shares of the company were exchanged, compared to its average volume of 31,487. STRATA Skin Sciences has a 52 week low of $0.26 and a 52 week high of $1.14. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.06. The firm has a 50 day moving average of $0.50 and a 200 day moving average of $0.52.

STRATA Skin Sciences (NASDAQ:SSKN) last released its quarterly earnings data on Wednesday, March 27th. The medical device company reported ($0.04) earnings per share for the quarter. The firm had revenue of $8.69 million during the quarter. STRATA Skin Sciences had a negative return on equity of 52.50% and a negative net margin of 32.47%. As a group, equities research analysts expect that STRATA Skin Sciences will post -0.19 earnings per share for the current year.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.